CNBX PHARMACEUTICALS INC. Payments of Stock Issuance Costs
CNBX PHARMACEUTICALS INC. (CNBX) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2020-08-31, per its 10-K filed 2020-11-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2020-11-04
- CNBX PHARMACEUTICALS INC. payments of stock issuance costs for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- CNBX PHARMACEUTICALS INC. payments of stock issuance costs for fiscal 2019 was $76.99K, a 9.42% decline from fiscal 2018.
- CNBX PHARMACEUTICALS INC. payments of stock issuance costs for fiscal 2018 was $85.00K, a 13.30% decline from fiscal 2017.
- CNBX PHARMACEUTICALS INC. payments of stock issuance costs for fiscal 2017 was $98.03K.
| Period end | Payments of Stock Issuance Costs 12 month |
|---|---|
| 2020-08-31 | $0.00 10-K · filed 2020-11-04 |
| 2019-08-31 | $76.99K 10-K · filed 2020-11-04 |
| 2018-08-31 | $85.00K 10-K · filed 2019-11-29 |
| 2017-08-31 | $98.03K 10-K · filed 2018-11-29 |
| 2016-08-31 | $0.00 10-K · filed 2017-12-08 |